| Number of Enrolled | Myanmarese (%) | Cambodian (%) | Karen (%) | Laotians (%) | Mons (%) | Thais (%) | Unknown (%) | Total (%) |
---|---|---|---|---|---|---|---|---|---|
Ethnicity | Malaria patients | 189 (74.1) | 8 (3.1) | 16 (6.3) | 2 (0.8) | 4 (1.6) | 35 (13.7) | 1 (0.4) | 255 |
Age | Median ± IQR (years) | 25.0 ± 15.0 | 24.5 ± 6.0 | 20.0 ± 7.0 | 28.0 | 21.5 ± 6.0 | 29.5 ± 15.0 | 16.0 | 25.0 ± 14.0 |
Range (years) | 14–057 | 19–30 | 14–40 | 24–32 | 19–26 | 16–60 | 16 | 14–60 | |
Sex | Male (%) | 182 (96.3) | 8 (100) | 16 (100) | 2 (100.0) | 4 (100.0) | 31 (88.6) | 1 (100.0) | 244 (95.7) |
Female (%) | 7 (3.7) | – | – | – | – | 4 (11.4) | – | 11 (4.3) | |
Plasmodium spp. | P. falciparum (%) | 81 (42.9) | 1 (12.5) | 7 (43.8) | 2 (100.0) | 1 (25.0) | 14 (40.0) | – | 106 (41.6) |
P. vivax (%) | 105 (55.6) | 6 (75.0) | 9 (56.3) | – | 3 (75.0) | 21 (60.0) | 1(100.0) | 145 (56.9) | |
Co-infection (Pf + Pv) (%) | 2 (1.1) | 1 (12.5) | – | – | – | – | – | 3 (1.2) | |
P. malariae (%) | 1 (0.5) | – | – | – | – | – | – | 1 (0.4) | |
G6PD (n = 45) | G6PD deficiency (%) | 19 (10.1) M:18, F:1 | 1 (12.5) M:1 | 3 (18.8) M:3 | – | – | 5 (14.3) M: 5 | – | 28 (11.0) M: 27 (11.1), F: 1 (9.1) |
G6PD intermediate (%) | 11 (5.8) M: 10, F: 1 | – | 1 (6.3) M: 1 | – | – | 5 (14.3) M: 3, F: 2 | – | 17 (6.7) M: 14 (5.7), F: 3 (27.3) | |
MahidolG487A mutation (%) | 14 (7.4) (Hemi: 13) (Homo: 1) | – | 2 (12.5) (Hemi: 2) | – | – | 2 (5.7) (Hemi: 2) | – | 18 (7.1) (Hemi: 17, Homo: 1) | |
MAF | |||||||||
Overall | |||||||||
 G allele (%) | 181 (92.3) | 8 (100.0) | 14 (87.5) | 2 (100.0) | 4 (100.0) | 37 (94.9) | 1 (100.0) | 242 (92.9) | |
 A allele (%) | 15 (7.7) | – | 2 (12.5) | – | – | 2 (5.1) | – | 19 (7.1) | |
 Male only |  |  |  |  |  |  |  |  | |
 G allele (%) | 169 (92.9) | 8 (100.0) | 14 (87.5) | 2 (100.0) | 4 (100.0) | 29 (93.6) | 1 (100.0) | 227 (93.0) | |
 A allele (%) | 13 (7.1) | – | 2 (12.5) | – | – | 2 (6.4) | – | 17 (7.0) | |
ViangchanG871A mutation (%) | – | 1 (100.0) (Hemi:1) | – | – | – | 2 (5.7) (Hemi: 2) | – | 3 (1.2) (Hemi: 3) | |
KaipingG1388A mutation (%) | – | – | 1 (6.3) (Hemi: 1) | – | – | – | – | 1 (0.4) (Hemi: 1) | |
AuresT143C mutation (%) | 1 (0.5) (Hemi: 1) | – | – | – | – |  | – | 1 (0.4) (Hemi: 1) | |
Unknown mutation (%) | 4 (2.1) | – | – | – | – | 1 (2.9) | – | 5 (2.0) | |
PKLR (n = 12) | PKLRR41Q mutation (%) | 9 (4.8) | 1 (12.5) | – | – | – | 2 (5.7) | – | 12 (4.7) |
Genotype G A (%) | 8 (88.9) | 1 (100.0) | – | – | – | 2 (100.0) | – | 11 (4.3) | |
Genotype A A (%) | 1 (11.1) | – | – | – | – | – | – | 1 (0.4) | |
MAF | |||||||||
 G allele (%) | 368 (97.4) | 15 (93.7) | 32 (100.0) | 4 (100.0) | 8 (100.0) | 68 (97.1) | 2 (100.0) | 497 (97.5) | |
 A allele (%) | 10 (2.6) | 1 (6.3) | – | – | – | 2 (2.9) | – | 13 (2.6) |